COVID-19 Vaccine: Serum Institute of India Restarts Manufacturing Covishield Vaccines, CEO Adar Poonawalla Confirms ‘6–7 Million Doses’ To Be Available in 90 Days
Serum Institute of India (SII) has restarted the manufacturing of Covishield Vaccines, amid the rising number of COVID-19 cases in the country. CEO Adar Poonawalla has confirmed ‘6–7 Million doses’ to be made available in 90 days.
- Read in
- తెలుగు
Amid the rising number of Covid-19 cases across the country, Serum Institute of India (SII) is going to restart the manufacturing of Covishield vaccines. The CEO OF SII, Adar Poonawalla, announced that "6-7 million doses available in 90 days". COVID-19 Surge in India: Coronavirus Moving Towards Endemic Stage, Cases May Rise for Next 10-12 Days.
Covidshield Vaccine Production Steadfast
Serum Institute of India restarts manufacturing Covishield vaccines, will make 6-7 million doses available in 90 days: CEO Adar Poonawalla
— Press Trust of India (@PTI_News) April 12, 2023
(The above story first appeared on LatestLY on Apr 12, 2023 05:21 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
